Total Clarity Wealth Management, Inc. Bria Cell Therapeutics Corp. Transaction History

Total Clarity Wealth Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$4.28 - $11.9 $13,631 - $37,901	3,185 New	3,185 $18,000
Q1 2022 Apr 29, 2022	SELL	$5.91 - $10.14 $93,484 - $160,394	-15,818 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$7.1 - $10.61 $31,190 - $46,609	4,393 Added 38.45%	15,818 $131,000
Q3 2021 Oct 21, 2021	BUY	$4.4 - $9.28 $50,270 - $106,023	11,425 New	11,425 $93,000

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $9.31M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.